ASD Holdings — Defiance Autism Impact ETF
All 39 reported holdings of Defiance Autism Impact ETF (ASD) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Definium Therapeutics Inc | 4.77% | $64.44K |
| Neuren Pharmaceuticals Ltd | 3.23% | $43.70K |
| LifeStance Health Group Inc | 3.04% | $41.10K |
| Otsuka Holdings Co Ltd | 2.95% | $39.89K |
| Acadia Healthcare Co Inc | 2.90% | $39.22K |
| ACADIA Pharmaceuticals Inc | 2.89% | $39.06K |
| MapLight Therapeutics Inc | 2.89% | $38.99K |
| AbbVie Inc | 2.72% | $36.74K |
| BrightSpring Health Services I | 2.70% | $36.54K |
| Revvity Inc | 2.68% | $36.27K |
| Bright Horizons Family Solutio | 2.65% | $35.87K |
| Medicover AB | 2.63% | $35.55K |
| Ipsen SA | 2.60% | $35.12K |
| Sumitomo Pharma Co Ltd | 2.60% | $35.09K |
| Johnson & Johnson | 2.59% | $35.05K |
| Brainsway Ltd | 2.58% | $34.90K |
| Pearson PLC | 2.56% | $34.64K |
| Anavex Life Sciences Corp | 2.53% | $34.23K |
| Novartis AG | 2.53% | $34.21K |
| Life Healthcare Group Holdings | 2.52% | $34.04K |
| BioMarin Pharmaceutical Inc | 2.52% | $33.99K |
| KPJ Healthcare Bhd | 2.51% | $33.95K |
| Repligen Corp | 2.50% | $33.84K |
| Roche Holding AG | 2.50% | $33.83K |
| Supernus Pharmaceuticals Inc | 2.50% | $33.77K |
| Jazz Pharmaceuticals PLC | 2.50% | $33.74K |
| Eli Lilly & Co | 2.49% | $33.58K |
| Bristol-Myers Squibb Co | 2.47% | $33.42K |
| Gsk PLC | 2.46% | $33.23K |
| Vanda Pharmaceuticals Inc | 2.45% | $33.15K |
| Graham Holdings Co | 2.37% | $31.96K |
| Teva Pharmaceutical Industries | 2.35% | $31.76K |
| Takeda Pharmaceutical Co Ltd | 2.35% | $31.72K |
| Grand Canyon Education Inc | 2.31% | $31.20K |
| H Lundbeck A/S | 2.29% | $30.98K |
| Shionogi & Co Ltd | 2.29% | $30.89K |
| Pfizer Inc | 2.25% | $30.39K |
| Stride Inc | 2.12% | $28.63K |
| First American Government Obli | 0.21% | $2.89K |